Core Cap Advisors, LLC Terns Pharmaceuticals, Inc. Transaction History
Core Cap Advisors, LLC
- $2.18 Billion
- Q1 2025
A detailed history of Core Cap Advisors, LLC transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, Core Cap Advisors, LLC holds 400 shares of TERN stock, worth $1,244. This represents 0.0% of its overall portfolio holdings.
Number of Shares
400Holding current value
$1,244% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TERN
# of Institutions
143Shares Held
84.5MCall Options Held
256KPut Options Held
133K-
Soleus Capital Management, L.P. Greenwich, CT8.17MShares$25.4 Million1.87% of portfolio
-
Orbimed Advisors LLC San Diego, CA7.56MShares$23.5 Million0.65% of portfolio
-
Morgan Stanley New York, NY7.11MShares$22.1 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA6.9MShares$21.4 Million5.17% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.58MShares$17.3 Million0.54% of portfolio
About Terns Pharmaceuticals, Inc.
- Ticker TERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,613,800
- Market Cap $117M
- Description
- Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...